Asencompany

Market position

An early-stage medical device developer working at prototype and pre-clinical-trial stage, with concept-stage product imagery and a patent portfolio spanning Korea, the United States, China and PCT filings.

Claims for LOXSA include non-invasive measurement without skin heating, results in under 10 seconds without calibration, and continuous 24-hour monitoring. The CGM is described as battery-free through supercapacitor power with reduced measurement lag and painless microneedle insertion. PATISA measures pressure, temperature and impedance in one sensor. The electroceutical patch is described as self-adhesive, stretchable and transparent, with electrodes that can be laid out uniformly or in patterns.

Technology

The core technology combines soft electronics with a proprietary bio-synthetic materials synthesis approach that confers electrical conductivity, light emission and energy storage or harvesting onto polymer substrates, allowing the substrate to act as a functional device or biosensor without added components. Specific implementations include a photoluminescence-based sensing film read by an optical module for transcutaneous oxygen partial-pressure measurement, a multi-parameter sensor combining pressure, temperature and impedance for pressure-ulcer detection, polymer microneedles with supercapacitor-based power for battery-free continuous glucose monitoring, and self-adhesive stretchable transparent electrodes for electrical stimulation patches. The company also cites research into the physical and chemical properties of material interfaces, their formation mechanisms and the resulting mechanical and functional changes, using both experimental and computational methods.

Go-to-market

Hospitals and clinicians monitoring inpatients and surgical patients, caregivers managing pressure-ulcer risk, patients requiring continuous glucose monitoring, and chronic wound and scar treatment.

Geography

Headquartered in Seoul, South Korea, at the Yonsei University Engineering Research Complex (50 Yonsei-ro, Seodaemun-gu), with separate manufacturing, research and integrated office facilities. Patent filings extend to the United States, China and PCT.

History

A directory listing gives a founding year of 2021 and a Seoul location. Leadership consists of CEO Sejeong Park, who holds master's and doctoral degrees in transportation engineering from the University of California, Berkeley and a bachelor's degree in urban engineering from Yonsei University, with prior roles as PMO Director at Ralph Lauren Hong Kong, manager at AT Kearney and consultant at Entrue Consulting Partners (LG CNS); and CTO Jinwoo Park, a professor in Yonsei University's Department of Advanced Materials Science and Engineering with a PhD in materials science from MIT, prior positions as senior researcher at Samsung Electro-Mechanics' central research institute (2003-2007), postdoctoral researcher at Oak Ridge National Laboratory and research assistant professor at the University of Tennessee, and service as associate dean for research at Yonsei's College of Engineering (2022-2023).

Risks & controversies

Products are presented with concept imagery rather than finished devices, and the oxygen sensor is described as being at the clinical-trial prototype stage, indicating regulatory approval and commercialization remain ahead.